| Auditorium 1 | Auditorium 2 | Auditorium 3 | Auditorium 4 | DAY 2 |
8:00 |
Registration |
|
|
|
8:00: |
8:05: |
|
|
8:05: |
8:10: |
|
|
8:10: |
8:15: |
|
|
8:15: |
8:20: |
|
|
8:20: |
8:25: |
|
|
8:25: |
8:30: |
|
|
8:30: |
8:35: |
|
|
8:35: |
8:40: |
|
|
8:40: |
8:45: |
|
|
|
8:45: |
8:50: |
|
|
|
8:50: |
8:55: |
|
|
|
8:55: |
9:00 |
|
|
|
|
9:00: |
9:05: |
|
|
|
|
9:05: |
9:10: |
|
|
|
9:10: |
9:15: |
|
|
|
9:15: |
9:20: |
|
|
|
9:20: |
9:25: |
|
|
|
9:25: |
9:30: |
|
|
|
9:30: |
9:35: |
|
|
|
9:35: |
9:40: |
|
|
|
9:40: |
9:45: |
|
|
|
9:45: |
9:50: |
Early Career Professional Introduction 09:50 (5 mins) Mark Soave, OMass Therapeutics
Pandemic response: accessible BSL3 platforms for drug discovery 09:55 (20 mins) Shaun Pennington, LSTM
|
|
|
|
9:50: |
9:55: |
|
|
|
9:55: |
10:00 |
|
|
|
10:00 |
10:05 |
|
|
|
10:05 |
10:10 |
|
|
|
10:10 |
10:15 |
|
|
|
|
10:15 |
10:20 |
Refreshment Break |
|
|
|
10:20 |
10:25 |
|
10:25 |
10:30 |
|
10:30 |
10:35 |
|
10:35 |
10:40 |
|
|
10:40 |
10:45 |
|
|
10:45 |
10:50 |
|
|
10:50 |
10:55 |
|
|
|
10:55 |
11:00 |
Session Introduction 11:00 (5 mins) Lisa Mohamet, GlaxoSmtihKline Samantha Barichievy, AstraZeneca AB
Biomarker Discovery Using Preclinical Models: Resources, Challenges and Opportunities 11:05 (30 mins) Benjamin Haibe-Kains, Princess Margaret Cancer Centre
Utilising complex in vitro gut models in drug discovery: they needn’t be hard to stomach 12:05 (30 mins) Nathaniel Lam, GSK
|
Session Introduction 11:00 (5 mins) Kathryn Chapman, Milner Therapeutics Institute, University of Cambridge David Powell, LifeArc
KQ Labs accelerator for data driven health start-ups: why does it exist, what does it do and what difference does it make? 11:05 (30 mins) Barbara Domayne-Hayman, Francis Crick Institute Jelena Aleksic, PharmEnable
The Joint AstraZeneca-Cancer Research Horizon Functional Genomics Centre (FGC): A partnership demonstrating how together we innovate faster and impact more 12:05 (30 mins) Douglas Ross-Thriepland, AstraZeneca
|
Session Introduction 11:00 (5 mins) Mario Richter, AbbVie Deutschland GmbH & Co. KG Kirsten Tschapalda, Roche
Efficient low-priced custom automation at Abbvie 11:05 (30 mins) Mario Richter, AbbVie Deutschland GmbH & Co. KG
iPSC automation platform 12:05 (30 mins) Martine Geraerts, UCB Biopharma
|
Session Introduction 11:00 (5 mins) A Ganesan, University Of East Anglia Martin Swarbrick, Ryvu Therapeutics Mary Wheldon, Drug Discovery Unit, University of Dundee Becky Garton, Royal Society of Chemistry
Platforms for the generation and high-throughput screening of cyclic peptide libraries. 11:05 (30 mins) Ali Tavassoli, Curve Therapeutics & University of Southampton
Green Chemistry at GSK - How and when to use guides, and using Green Chemistry to design a scalable route to a first-in-class BET BD2 inhibitor 11:35 (30 mins) Catherine Alder, GSK
Ligand discovery in dark chemical space leading to biological insights 12:05 (30 mins) John Irwin, University of California San Francisco
|
11:00 |
11:05 |
11:05 |
11:10 |
11:10 |
11:15 |
11:15 |
11:20 |
11:20 |
11:25 |
11:25 |
11:30 |
11:30 |
11:35 |
11:35 |
11:40 |
11:40 |
11:45 |
11:45 |
11:50 |
11:50 |
11:55 |
11:55 |
12:00 |
12:00 |
12:05 |
12:05 |
12:10 |
12:10 |
12:15 |
12:15 |
12:20 |
12:20 |
12:25 |
12:25 |
12:30 |
12:30 |
12:35 |
12:35 |
12:40 |
12:40 |
12:45 |
12:45 |
12:50 |
Refreshment Break - Poster Session 13.15 - 13.45 |
|
|
|
12:50 |
12:55 |
|
12:55 |
1:00 |
|
1:00: |
1:05: |
|
1:05: |
1:10: |
|
|
1:10: |
1:15: |
|
|
1:15: |
1:20: |
|
|
1:20: |
1:25: |
|
|
1:25: |
1:30: |
|
|
1:30: |
1:35: |
|
1:35: |
1:40: |
|
1:40: |
1:45: |
|
1:45: |
1:50: |
|
|
|
1:50: |
1:55: |
|
|
|
1:55: |
2:00 |
Organoid Biobanks for Cancer Drug Discovery 14:00 (30 mins) Mathew Garnett, Wellcome Sanger Institute
Upgrading African disease-in-a-dish models for pharmacovigilance: Enter the humble cell 14:40 (30 mins) Janine Scholefield, CSIR, South Africa
|
The Drug Discovery Unit: Leading the development of new anti-infective treatments with a collaborative approach 14:00 (30 mins) Beatriz Baragana, Drug Discovery Unit, University of Dundee
Dementia Drugs through Partnership at the ALBORADA Drug Discovery Institute 14:40 (30 mins) John Skidmore, University of Cambridge
|
Collaborative AMR Implementation in Biopharmaceutical Labs 14:00 (30 mins) Thomas Albanetti, AstraZeneca
An Educational Approach for Drug Discover Using AI Driven Closed Loop Experimentation 14:40 (30 mins) Joshua Kangas, Carnegie Mellon University
|
Discovery of the clinical candidate, ASTX029, a dual mechanism ERK inhibitor 14:00 (30 mins) Nicola Wallis, Astex
The Discovery and Clinical Efficacy of Sisunatovir 14:40 (30 mins) Stuart Cockerill, Reviral/Pfizer
|
2:00: |
2:05: |
2:05: |
2:10: |
2:10: |
2:15: |
2:15: |
2:20: |
2:20: |
2:25: |
2:25: |
2:30: |
2:30: |
2:35: |
2:35: |
2:40: |
2:40: |
2:45: |
2:45: |
2:50: |
2:50: |
2:55: |
2:55: |
3:00 |
3:00: |
3:05: |
3:05: |
3:10: |
Refreshment Break |
|
|
|
3:10: |
3:15: |
|
|
|
3:15: |
3:20: |
|
|
3:20: |
3:25: |
|
|
3:25: |
3:30: |
|
|
3:30: |
3:35: |
|
|
|
3:35: |
3:40: |
|
|
|
3:40: |
3:45: |
Generating improved preclinical models for profiling novel combinations 15:45 (30 mins) Elizabeth Hardaker, Astrazeneca
Image-based drug screening in patient biopsies for personalized systems medicine and drug discovery 16:15 (30 mins) Berend Snijder , ETH Zurich
|
The benefits of working side-by-side: The Crick-GSK Biomedical LinkLabs collaboration. 15:45 (30 mins) Katrin Rittinger, Francis Crick Institute Andrew Powell, GlaxoSmithKline
Advancing UK Medicines Discovery through Innovative Partnerships 16:15 (30 mins) Martin Main, Medicines Discovery Catapult
|
Enhancing the lead discovery assay value chain by an orchestrated lab automation ecosystem 15:45 (30 mins) Federica Morandi, F Hoffmann-La Roche Kirsten Tschapalda, Roche
High Throughput Affinity Screening for Rapid Hit Discovery and Prosecuting Challenging Targets 16:15 (30 mins) Poppy Llowarch, AstraZeneca
|
Discovery and Development of Pyrukynd®: The First-in-Class Pyruvate Kinase Activator For The Treatment of Hemolytic Anemia 15:45 (30 mins) Lenny Dang, Agios Pharmaceuticals Inc
Simplifying Synthesis with Electricity 16:15 (45 mins) Phil Baran, Scripps Research Institute
|
3:45: |
3:50: |
3:50: |
3:55: |
3:55: |
4:00 |
4:00: |
4:05: |
4:05: |
4:10: |
4:10: |
4:15: |
4:15: |
4:20: |
4:20: |
4:25: |
4:25: |
4:30: |
4:30: |
4:35: |
4:35: |
4:40: |
4:40: |
4:45: |
|
|
|
4:45: |
4:50: |
|
|
|
4:50: |
4:55: |
|
|
|
4:55: |
5:00 |
|
|
|
|
5:00: |
5:05: |
|
|
|
|
5:05: |
5:10: |
|
|
|
|
5:10: |
5:15: |
|
|
|
|
5:15: |
5:20: |
|
|
|
|
5:20: |
5:25: |
|
|
|
|
5:25: |
5:30: |
|
|
|
|
5:30: |
5:35: |
|
|
|
|
5:35: |
5:40: |
|
|
|
|
5:40: |
5:45: |
|
|
|
|
5:45: |
5:50: |
|
|
|
|
5:50: |
5:55: |
|
|
|
|
5:55: |
6:00 |
|
|
|
|
6:00: |
6:05: |
|
|
|
|
6:05: |
6:10: |
|
|
|
|
6:10: |
6:15: |
|
|
|
|
6:15: |
6:20: |
|
|
|
|
6:20: |
6:25: |
|
|
|
|
6:25: |
6:30: |
|
|
|
|
6:30: |
6:35: |
|
|
|
|
6:35: |
6:40: |
|
|
|
|
6:40: |
6:45: |
|
|
|
|
6:45: |
6:50: |
|
|
|
|
6:50: |
6:55: |
|
|
|
|
6:55: |
7:00 |
|
|
|
|
7:00: |